Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.58
0.164.68%
At close: -
$3.27
-0.31-8.64%
After Hours: Mar 20, 4:43 PM EDT
Comments
Loading...
BioLine Rx (BLRX) Forecast
NewsEarningsBioLine Rx (BLRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
BioLine Rx Stock Price, Quotes and Forecasts | NASDAQ:BLRX | Benzinga
Explore BioLine Rx stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BLRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioLine Rx (BLRX) stock?
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Who are BioLine Rx (BLRX) competitors?
Other companies in BioLine Rx’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).
What is the forecast, or price target, for BioLine Rx (BLRX) stock?
BioLine Rx has a consensus price target of $5.00.
What is the current price for BioLine Rx (BLRX)?
The stock price for BioLine Rx (NASDAQ: BLRX) is $3.2706 last updated March 20, 2025 at 4:43 PM EDT.
Does BioLine Rx (BLRX) pay a dividend?
There are no upcoming dividends for BioLine Rx.
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx’s Q1 earnings are confirmed for Tuesday, May 27, 2025.
Is BioLine Rx (BLRX) going to split?
There is no upcoming split for BioLine Rx.
What sector and industry does BioLine Rx (BLRX) operate in?
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.